These posters, oral presentations, and/or abstracts are provided for medical and scientific purposes only, they may include investigational use or agents that are not approved by health authorities. The information presented is not meant to convey conclusions of safety or effectiveness prior to any regulatory approval from a health authority.
Sanofi does not recommend the use of any products in a manner inconsistent with that described in the full prescribing information. Please refer to the prescribing information in your country of practice for any medicinal products mentioned.
Availability of posters and/or abstracts on this site will conform with conference embargo policies. By selecting “Accept”, you are certifying that you are a Healthcare Professional.
ISTH 2024 | Jun 22, 2024 - Jun 26, 2024
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare blood disorder that develops when the immune system stops a key enzyme (ADAMTS13) from working properly. Without this protein, the body creates too many blood clots.
